Skip to content
Screener

Guardian Pharmacy Services GRDN Q2 2025 earnings

Reported August 11, 2025 · After market close

Revenue$344.3MBeat by $185.7K
EPS$0.23Beat by $0.01
Revenue estimate$344.1M
EPS estimate$0.22

Next report

Date not yet announced

Financials

Q2 2025

Income statement

See full
Revenue$344.3M+14.8%
Gross profit$68.1M+11.2%
Operating income$12.6M-26.0%
Net income$9.0M—
EPS (diluted)$0.14—

Balance sheet

See full
Cash & equivalents$18.8M—
Total debt$33.7M—
Total equity$179.7M—
Total assets$356.3M—

Cash flow

See full
Operating cash flow$19.9M-31.6%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1.3B—
Enterprise value$1.32B—
P/S1×—

Profitability

See full
Gross margin19.6%-0.3pp
Net margin-7.8%-9.1pp

Returns & leverage

See full
Debt / equity0.2×—
Current ratio1.2×—

Segments

By segment

See full
Corporate$344.3M+14.8%

FAQ

When did Guardian Pharmacy Services report Q2 2025 earnings?
Guardian Pharmacy Services (GRDN) reported Q2 2025 earnings on August 11, 2025 after market close.
What were Guardian Pharmacy Services's Q2 2025 revenue and EPS?
Guardian Pharmacy Services reported revenue of $344.3M and eps of $0.23 for Q2 2025.
Did Guardian Pharmacy Services beat estimates in Q2 2025?
Revenue beat the consensus estimate of $344.1M by $185.7K. EPS beat the consensus estimate of $0.22 by $0.01.
How did Guardian Pharmacy Services's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.8% from $300.0M a year earlier and eps grew 31.7% from $0.17.
Where can I find Guardian Pharmacy Services's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-177963) and the 10-Q periodic report (0001193125-25-177969) directly on SEC EDGAR. The filing index links above go to sec.gov.